Skip to main content
. 2017 May 11;8(26):43140–43152. doi: 10.18632/oncotarget.17814

Table 3. The three dimensions interactions of the ERCC6 rs1917799-ERCC8 rs158572-ERCC8 rs158916 with the risk of GC and CAG.

SNP genotypes CAG vs. CSG GC vs. CSG
P OR(95%CI) P OR(95%CI)
ERCC6 rs1917799-ERCC8 rs158572-ERCC8 rs158916
TT AA TT 1(ref) 1(ref)
TT AA CT/CC 0.375 1.24(0.77-1.97) 0.188 1.44(0.84-2.49)
TT GA/GG TT 0.031 1.97(1.07-3.63) 0.006 2.75(1.33-5.55)
TT GA/GG CT/CC 0.088 0.23(0.04-1.25) 0.362 1.74(0.53-5.72)
GT/GG AA TT 0.718 1.06(0.79-1.41) 0.013 1.56(1.10-2.20)
GT/GG AA CT/CC 0.153 0.75(0.51-1.11) 0.962 1.01(0.64-1.59)
GT/GG GA/GG TT 0.032 0.61(0.39-0.96) 0.252 1.33(0.81-2.20)
GT/GG GA/GG CT/CC 0.074 0.27(0.07-1.14) 0.818 0.86(0.24-3.10)
Pinteraction=0.119 Pinteraction=0.429
interaction index=6.61 interaction index=2.23

CSG: chronic superficial gastritis; CAG: chronic atrophic gastritis; GC: gastric cancer.